Viscogliosi Brothers Acquisition Corp.
VBOCW
NASDAQ Global Market0.00
USD
+0.00
- -
CIK
0001853920
CUSIP
92838K118
Return %
Stock
S&P500
1Y
-95.56
26.53
3Y
-98.40
76.60
5Y
-98.40
80.11
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- John J. Viscogliosi
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 505 Park Avenue New York City NY United States of America 10022
- IPO Date
- Feb 28, 2022
- CIK
- 0001853920
- Website
- vb-oc.com
- Similar Companies
- Business
- Viscogliosi Brothers Acquisition Corp. (VBOCW) operates as a blank check company whose purpose is to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities, with a focus on the neuro-musculoskeletal industry including implantable devices, services, regenerative medicine, and contract manufacturing sectors primarily in North America and Europe; it offers no current products or services beyond this acquisition mandate. Incorporated in 2020 and headquartered at 505 Park Avenue, 14th Floor, New York, New York, the company went public in January 2022 raising approximately $86.25 million in its initial public offering of units listed on Nasdaq under VBOCU, with common stock as VBOC and warrants as VBOCW exercisable at $11.50. In July 2023, following failure to identify and complete a suitable business combination within the required timeframe and cancellation of a shareholder meeting for deadline extension, the company redeemed all public shares effective July 11, 2023, ceased operations, dissolved, and liquidated in accordance with its charter, with warrants expiring worthless and no liquidating distributions provided to warrant holders. The sponsor, an affiliate of Viscogliosi Brothers, LLC—a family investment office led by brothers Anthony, John, and Marc Viscogliosi with extensive experience in neuro-musculoskeletal investments—holds private placement warrants but the entity maintains no active operations, subsidiaries, or ongoing strategic activities post-liquidation.